Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism ; volume:13 ; number:1 ; day:1 ; month:3 ; year:2023 ; pages:1-2 ; date:12.2023
EJNMMI Research ; 13, Heft 1 (1.3.2023), 1-2, 12.2023
- Urheber
-
Marner, Lisbeth
Korsholm, Kirsten
Anderberg, Lasse
Lonsdale, Markus N.
Jensen, Mads Radmer
Brødsgaard, Eva
Denholt, Charlotte L.
Gillings, Nic
Law, Ian
Friberg, Lars
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-023-00970-x
- URN
-
urn:nbn:de:101:1-2023121109532772611368
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Marner, Lisbeth
- Korsholm, Kirsten
- Anderberg, Lasse
- Lonsdale, Markus N.
- Jensen, Mads Radmer
- Brødsgaard, Eva
- Denholt, Charlotte L.
- Gillings, Nic
- Law, Ian
- Friberg, Lars
- SpringerLink (Online service)
Ähnliche Objekte (12)
![[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism](/assets/placeholder/searchResultMediaUnknown.png)
[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indices
Single-site 123I-FP-CIT reference values from individuals with non-degenerative parkinsonism—comparison with values from healthy volunteers
Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT
Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting
CYP3A4 inhibitors may influence the quantification of [123I]I-FP-CIT SPECT scans
Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes
Influence of CT-based attenuation correction on dopamine transporter SPECT with [123I]FP-CIT
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
[123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies
![Prognostische Wertigkeit der [123I]FP-CIT SPECT bei Patienten mit klinischem Verdacht auf eine neurodegenerative Erkrankung](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Prognostische Wertigkeit der [123I]FP-CIT SPECT bei Patienten mit klinischem Verdacht auf eine neurodegenerative Erkrankung
[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indices
Single-site 123I-FP-CIT reference values from individuals with non-degenerative parkinsonism—comparison with values from healthy volunteers
Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT
Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting
CYP3A4 inhibitors may influence the quantification of [123I]I-FP-CIT SPECT scans
Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes
Influence of CT-based attenuation correction on dopamine transporter SPECT with [123I]FP-CIT
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
[123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies
Prognostische Wertigkeit der [123I]FP-CIT SPECT bei Patienten mit klinischem Verdacht auf eine neurodegenerative Erkrankung
[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal 123I-FP-CIT indices
Single-site 123I-FP-CIT reference values from individuals with non-degenerative parkinsonism—comparison with values from healthy volunteers
Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT
Computer-aided diagnosis for (123I)FP-CIT imaging: impact on clinical reporting
CYP3A4 inhibitors may influence the quantification of [123I]I-FP-CIT SPECT scans
Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes
Influence of CT-based attenuation correction on dopamine transporter SPECT with [123I]FP-CIT
Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
[123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies